Effect of Spironolactone on QRS Duration in Patients at Risk for Heart Failure (from the HOMAGE Trial).

Ferreira, João Pedro; Cleland, John GF; Girerd, Nicolas; Pellicori, Pierpaolo; Hazebroek, Mark R; Verdonschot, Job; Collier, Timothy J; Petutschnigg, Johannes; Clark, Andrew L; Staessen, Jan A; +3 more... Heymans, Stephane; Rossignol, Patrick; Zannad, Faiez; (2023) Effect of Spironolactone on QRS Duration in Patients at Risk for Heart Failure (from the HOMAGE Trial). The American journal of cardiology, 191. pp. 39-42. ISSN 0002-9149 DOI: https://doi.org/10.1016/j.amjcard.2022.12.016

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/j.amjcard.2022.12.016

Abstract

Share

Download

Filename: Ferreira_etal_2023_Effect-of-spironolactone-on-qrs.pdf

Description: This is an author accepted manuscript version of an article accepted for publication, and following peer review. Please be aware that minor differences may exist between this version and the final version if you wish to cite from it.

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 4.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar